Aptevo Therapeutics Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:APVO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 8.34 M15.62 M27 M27.19 M19.9 M Total liabilities 9.81 M9.1 M9.6 M9.81 M8.29 M Total equity -1.47 M6.52 M17.39 M17.38 M11.61 M Total liabilities & shareholders' equities 8.34 M15.62 M27 M27.19 M19.9 M Total debt ————— Net debt —————

News

All You Need to Know About Aptevo Therapeutics (APVO) Rating Upgrade to Buy

Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why

Aptevo Therapeutics stock tumbles despite positive trial data

Aptevo Therapeutics announces leadership changes as CEO retires

Aptevo Therapeutics stock jumps after securing $60 million equity line

Aptevo secures $60 million equity line of credit to fund operations

Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis

Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested - TipRanks.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.04%

Aptevo Therapeutics stock tumbles after announcing 1-for-18 reverse split

Aptevo Therapeutics to implement 1-for-18 reverse stock split

What's Going On With Aptevo Therapeutics Stock Today? - Aptevo Therapeutics (NASDAQ:APVO)